Assignee
NEBOLSIN VLADIMIR EVGENIEVICH
RU·5 granted patents·4 pending applications·10 citations·filing 2006–2023
Top patents by PatentIndex Score
9 records- 0181US8318950B2N-acyl amino acid derivatives, a method for the preparation thereof, a pharmaceutical composition and use thereof as anti-allergic, anti-inflammatory and hypolipidemic agentsNEBOLSIN VLADIMIR EVGENIEVICH·Filed 2010·Granted Nov 27, 2012·7 cites·3 claims
- 0272US8309766B2Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereofNEBOLSIN VLADIMIR EVGENIEVICH·Filed 2006·Granted Nov 13, 2012·2 cites·8 claims
- 0372US2024116898A1Novel glutaminyl cyclase inhibitors and the use thereof in treatment of various diseasesNEBOLSIN VLADIMIR EVGENIEVICH·Filed 2023·Application pending·0 cites
- 0459US9504673B2Agent for the prophylaxis and treatment of highly pathogenic infectious diseasesNEBOLSIN VLADIMIR EVGENIEVICH·Filed 2010·Granted Nov 29, 2016·1 cites·9 claims
- 0555US2011224213A1Use of Glutaric Acid Derivatives or the Pharmaceutically Acceptable Salts Thereof as Anti-Arrhythmic AgentsNEBOLSIN VLADIMIR EVGENIEVICH·Filed 2009·Application pending·0 cites
- 0652US8940780B2N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form anti-allergic, anti-inflammatory and hypolipidemic agentsNEBOLSIN VLADIMIR EVGENIEVICH·Filed 2006·Granted Jan 27, 2015·0 cites·17 claims
- 0748US2014357587A1Use of Glutaryl Histamine for the Treatment of Respiratory Tract DiseasesNEBOLSIN VLADIMIR EVGENIEVICH·Filed 2012·Application pending·0 cites
- 0845US2017143674A1Use of Glutaryl Histamine for the Treatment of Respiratory Tract DiseasesNEBOLSIN VLADIMIR EVGENIEVICH·Filed 2016·Application pending·0 cites
- 0935US8906897B2Antimicrobial agents based on hemin derivativesNEBOLSIN VLADIMIR EVGENIEVICH·Filed 2010·Granted Dec 9, 2014·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when NEBOLSIN VLADIMIR EVGENIEVICH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →